The US FDA issued a Warning Letter to International Laboratories Corp in Thailand for significant data integrity and documentation violations identified during an inspection. Key issues included:
In response, the manufacturer acknowledged deficiencies but did not provide a comprehensive assessment. The FDA required the company to:
For further details, the FDA Warning Letter is available on the FDA website.
25-04-2025